Samuel Atack appointed as Operations Director at Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst are delighted to announce that Samuel Atack will be stepping into the role of Operations Director at Stevenage Bioscience Catalyst on 1st April 2025 when current Operations Director Dave Mudd retires.
Why your organisation needs Microsoft 365 Business Premium
If you use Microsoft 365 Business Standard, you’ll already know about the range of tools and features that help your business function better every day ....
42 Technology appoints Dr Peter Brown as Chief Commercial Officer
42 Technology (42T) has appointed Dr Peter Brown as its first Chief Commercial Officer (CCO). In this newly-created role, Peter will now oversee all global sales and business development activities and help drive the company’s expansion across its five industry sectors: consumer, energy, life sciences, medtech and industrial. He also joins the company’s board of directors with immediate effect.
Guardtech encouraging new clients to book ‘game-changing’ visit to their Cleancube Showroom
Suffolk-based firm have thrown open the doors of their award-winning shipping container solution to show Life Sciences firms what the fuss is all about
Alignment Cubed kicks off the 2025 Norwich Research Park Entrepreneur Network Masterclass Series
Last week, Alignment Cubed co-founders Majid Islam and Jonathan Pearce were thrilled and proud to kick off the new series of 2025 masterclasses, being provided exclusively to members of the Norwich Research Park Entrepreneur Network.
China's medical innovation: Hengrui launches breakthrough ECMO technology
Jiangsu Hengrui Pharmaceuticals Co., Ltd. has achieved a significant milestone in China's medical device industry. The company's domestically developed Extracorporeal Membrane Oxygenation (ECMO) system received approval from China's National Medical Products Administration on January 24, 2025.
Most engineered human cells created for studying disease
Researchers have engineered and analysed many random versions of human genomes in cell lines to ultimately understand the role of structural changes in disease.
Patient who overcame brain tumour to play key role in ‘super-survivor’ cancer study
A woman from Cambridge who is living life to the full, five years after being diagnosed with an aggressive brain tumour, is hoping to take part in a trial aimed at unlocking the secrets of why some cancer patients survive longer than others.
Chancellor of the Exchequer: Cambridge to drive rapid research-led economic growth
Cambridge is at the heart of Government plans announced today to go ‘further and faster’ to kick start economic growth in the UK.
Daniel Zeichner MP welcomes major investment in Cambridge
Daniel Zeichner, MP for Cambridge, has welcomed the Chancellor’s ambitious plans to unlock economic growth in the Oxford-Cambridge Growth Corridor, which are set to deliver significant benefits for Cambridge’s housing, transport and science sectors. The government’s Plan for Change, being announced today by Chancellor Rachel Reeves, will accelerate investment and strengthen Cambridge’s position…
Trilobio introduces whole-laboratory automation platform at SLAS2025
· First public demonstration of unified robotics, device and software platform to be showcased at SLAS2025, 25-29 January, in San Diego, CA. Booth 2115
The innovation mirage: A deep tech perspective from CES 2025
There's something profoundly surreal about standing amidst humanity's technological frontier.
Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure
Configurable informatics platform improves lab efficiency, data tracking, and resource management from plasmid to structure
Bio-Rad launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for Antibody Conjugation to StarBright Dyes
New Kits Offer Broad Antibody Compatibility and Long-Term Stability for Flow Cytometry and Western Blot Applications
electronRx Reflects on CES 2025
CES, the Consumer Electronics Show, is the world's largest and most influential technology event, held annually in Las Vegas since 1967.
Tecan introduces Veya: bringing digital, scalable automation to labs worldwide
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
The transformative potential of MedTech innovation
MedTech holds vast potential to reshape healthcare. AI-powered diagnostics, personalized medicine, and real-time monitoring devices are bringing care closer to patients in ways that can both enhance outcomes and lower costs. Tony Kypreos, Accelerate Cambridge Coach, entrepreneur and investor talks about the key stages of the MedTech startup journey in our latest blog.
Milner Institute partners with Flagship Pioneering and CUHP to accelerate biotech research and innovation
The Milner Therapeutics Institute are delighted to announce a new collaboration with Flagship Pioneering and Cambridge University Health Partners (CUHP), to jointly advance breakthrough scientific research and technologies.
Surgery ‘Super Sunday’ breaks operation record
A team at Addenbrooke’s Hospital has carried out a record number of gall bladder operations in a single day using high-tech robots that assist with keyhole surgery.
Sphere Fluidics launches Cyto-Mine Chroma and announces Early Access Program
Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D
ELRIG announces Drs Jue Wang and Robert Grundy as keynote speakers at Research & Innovation 2025
• ELRIG Research & Innovation 2025 takes place in London, UK from 10–11 March • Event will focus on ‘Big molecules to big data…thinking BIG to drive innovative research’
Magic at the Mill Christmas Parties 2025 Launches
Step into a magical winter wonderland at Cambridge's most enchanting Christmas party destination!
Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery Company also announces key accreditations in recognition of excellence in data security,
Daniel Zeichner MP hails Labour’s green light for Cambridge Cancer Hospital
Following the publication of the Labour Government’s review of the New Hospital Programme, funding has today (Monday 20th January) been confirmed and a green light given for Cambridge Cancer Research Hospital.
Bio-Rad extends range of Vericheck ddPCR Empty-Full Capsid Kits to optimize AAV Vector Characterization
New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid Titer, Supporting Reliable Assessment of AAV Vector Quality